SITC Archive Library

2017-2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Los Angeles Webinar 2 

08-28-2019 10:50

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the 2017 Los Angeles event is provided here. The purpose of this webinar series is to help attendees of the ACI program stay connected with regional experts, ask questions and receive guidance from program organizers.

Webinar Faculty:

  • Kim A. Margolin, MD – City of Hope
  • Teresa Kim, RN, BSN – City of Hope

This webinar addressed the following questions:
  • What side effects of immunotherapy require immediate attention?
  • What are other medications are being investigated to mitigate side effects of immunotherapy other then prednisone and mycophenolate?
  • What roles can a RN play in advancing and promoting use of IO?
  • What side effects are "manageable" to the oncologist vs. what is "manageable" to the patient?
  • Do you have a panel of blood work that you run routinely on patients who are on treatment?
  • Do you treat endocrine numbers or watch?
  • What is a therapeutic dose of steroids?

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.


0 Favorited
1 Files
mp4 file
2017 Advances in Cancer Immunotherapy™ Post Program Webin...   24.41 MB   1 version
Uploaded - 08-28-2019
Presenters: Kim A. Margolin, MD – City of Hope, Teresa Kim, RN, BSN – City of Hope; Length: 36:40

Related Entries and Links

No Related Resource entered.